WEBULL
News
TXG
19.15
+3.29%
0.61
Weekly Report: what happened at TXG last week (0202-0206)?
Weekly Report · 1d ago
Is 10x Genomics (TXG) Using PharosAI’s NHS Partnership To Quietly Recast Its Spatial Biology Moat?
Simply Wall St · 2d ago
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), 10x Genomics (TXG) and Oruka Therapeutics (ORKA)
TipRanks · 5d ago
10x Genomics und PharosAI gründen Konsortium zur KI-gestützten Krebsforschung
Reuters · 6d ago
10x Genomics and PharosAI Launch Consortium to Build Multimodal Cancer Dataset
Reuters · 6d ago
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
PR Newswire · 6d ago
Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT
Seeking Alpha · 02/02 12:30
Weekly Report: what happened at TXG last week (0126-0130)?
Weekly Report · 02/02 09:19
Gold, Silver Crash Sparks Mining Meltdown: 10 Stocks Crater On Fed Warsh Shock
Benzinga · 01/30 19:48
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?
Barchart · 01/30 11:33
Breaking Down 10x Genomics: 13 Analysts Share Their Views
Benzinga · 01/27 21:01
10x Genomics Price Target Cut to $20.00/Share From $22.00 by Leerink Partners
Dow Jones · 01/27 18:53
10x Genomics Is Maintained at Market Perform by Leerink Partners
Dow Jones · 01/27 18:53
Cathie Wood's weekly recap: buys WeRide, crypto names, trims defense firm Kratos, PINS, META
Seeking Alpha · 01/27 11:15
Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide
TipRanks · 01/27 03:30
Okta Appoints Rebecca Port as Chief People Officer
Reuters · 01/26 17:02
10x Genomics and BioTuring Partner to Streamline Single Cell and Spatial Data Analysis
Reuters · 01/26 14:01
Weekly Report: what happened at TXG last week (0119-0123)?
Weekly Report · 01/26 09:19
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance
Simply Wall St · 01/25 19:14
Cathie Wood Buys the Dip in Broadcom and Crypto Stocks, Sells $8M in Meta
TipRanks · 01/24 13:30
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.